(0.04%) 5 471.75 points
(0.09%) 39 147 points
(0.36%) 17 782 points
(0.01%) $80.84
(-3.66%) $2.66
(-0.80%) $2 312.10
(0.18%) $28.92
(3.45%) $1 020.40
(0.27%) $0.936
(0.68%) $10.68
(0.43%) $0.792
(-0.27%) $87.25
Live Chart Being Loaded With Signals
Coeptis Therapeutics Holdings, Inc., a biopharmaceutical company, develops and commercializes generic and branded pharmaceutical products and cell therapy platforms for patients with cancer...
Stats | |
---|---|
今日成交量 | 7 099 |
平均成交量 | 0 |
市值 | 15.43M |
EPS | $-0.0844 ( Q1 | 2024-05-10 ) |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E |
0 (Sector) 42.63 (Industry) 24.32 |
ATR14 | $0 (0.00%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-01-10 | Cogley Brian | Buy | 5 000 | Common Stock |
2024-01-10 | Cogley Brian | Sell | 0 | Common Stock |
2024-01-12 | Desilva Tara | Buy | 1 800 | Common Stock |
2024-01-12 | Desilva Tara | Buy | 466 | Common Stock |
2024-01-05 | Yerace Daniel Alexander | Buy | 10 850 | Common Stock |
INSIDER POWER |
---|
-74.77 |
Last 21 transactions |
Buy: 105 996 | Sell: 1 403 923 |
Coeptis Therapeutics 相关性
10 最正相关 |
---|
10 最负相关 |
---|
你知道吗?
相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1,其中-1表示完全负相关(一个变量增加,另一个变量减少),1表示完全正相关(一个变量增加,另一个变量也增加),0表示没有相关性(变量之间没有关系)。
相关性可用于分析任何两个变量之间的关系,而不仅仅是股票。它通常用于金融、经济学、心理学等领域。
Coeptis Therapeutics 财务报表
Annual | 2023 |
营收: | $0 |
毛利润: | $-1.00M (0.00 %) |
EPS: | $-0.830 |
FY | 2023 |
营收: | $0 |
毛利润: | $-1.00M (0.00 %) |
EPS: | $-0.830 |
FY | 2022 |
营收: | $0 |
毛利润: | $-1.00M (0.00 %) |
EPS: | $-2.87 |
Financial Reports:
No articles found.
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Coeptis Therapeutics
Coeptis Therapeutics Holdings, Inc., a biopharmaceutical company, develops and commercializes generic and branded pharmaceutical products and cell therapy platforms for patients with cancer. Its product portfolio consists of CD38-GEAR-NK, a Vy-Gen drug product for the treatment of CD38-related cancers, including multiple myeloma, chronic lymphocytic leukemia, and acute myeloid leukemia; and CD38-Diagnostic, an in vitro screening tool to provide the ability to pre-determine which cancer patients are most likely to benefit from targeted anti-CD38 monoclonal antibodies therapies. The company has collaboration with Statera BioPharma to develop and commercialize STAT-201 for Crohn\'s disease; and Vici Health Sciences, LLC to co-develop and share ownership rights to CPT60621 for the treatment of Parkinson\'s Disease. Coeptis Therapeutics Holdings, Inc. was founded in 2017 and is headquartered in Wexford, Pennsylvania.
关于 实时信号
此页面上呈现的实时信号有助于确定何时购买或出售NA. 信号具有高达1分钟的延迟;与所有市场信号一样,存在误差或错误的可能性。
实时交易信号不是绝对的,getagraph.com 对基于这些信号采取的任何行动概不负责,如《使用条款》中所述。这些信号是基于广泛的技术分析指标。